Picking the optimal target for antibody-drug conjugates
- PMID: 23714470
- DOI: 10.14694/EdBook_AM.2013.33.e103
Picking the optimal target for antibody-drug conjugates
Abstract
Antibody-drug conjugates (ADCs) combine the cytotoxic potential of chemotherapeutic drugs with the specificity of monoclonal antibodies (mAbs). After many years of unfulfilled promise, the field of ADCs is experiencing resurgence as more is learned about each of the components of an ADC and how these components need to be combined to produce a successful therapeutic agent. Choosing an appropriate target for ADCs is a critical parameter that effects the efficacy, therapeutic window, and toxicity profile of ADCs. This review will focus on the concepts underlying the choice of the target, review specific current ADCs and their targets, and look to the future of ADCs.
Similar articles
-
Antibody-drug conjugates in hematologic malignancies.Am Soc Clin Oncol Educ Book. 2013. doi: 10.14694/EdBook_AM.2013.33.e108. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714472 Review.
-
Antibody drug conjugates: Progress, pitfalls, and promises.Hum Antibodies. 2019;27(1):53-62. doi: 10.3233/HAB-180348. Hum Antibodies. 2019. PMID: 30223393 Review.
-
Antibody-Drug Conjugates for Cancer Therapy.Molecules. 2020 Oct 16;25(20):4764. doi: 10.3390/molecules25204764. Molecules. 2020. PMID: 33081383 Free PMC article. Review.
-
Resistance to Antibody-Drug Conjugates.Cancer Res. 2018 May 1;78(9):2159-2165. doi: 10.1158/0008-5472.CAN-17-3671. Epub 2018 Apr 13. Cancer Res. 2018. PMID: 29653942 Review.
-
Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.J Cell Physiol. 2018 Sep;233(9):6441-6457. doi: 10.1002/jcp.26435. Epub 2018 Mar 25. J Cell Physiol. 2018. PMID: 29319167 Review.
Cited by
-
Antibody-drug conjugates as novel anti-cancer chemotherapeutics.Biosci Rep. 2015 Jun 12;35(4):e00225. doi: 10.1042/BSR20150089. Biosci Rep. 2015. PMID: 26182432 Free PMC article. Review.
-
Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy.Molecules. 2017 Aug 1;22(8):1281. doi: 10.3390/molecules22081281. Molecules. 2017. PMID: 28763044 Free PMC article. Review.
-
Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them?Front Oncol. 2021 Dec 3;11:718590. doi: 10.3389/fonc.2021.718590. eCollection 2021. Front Oncol. 2021. PMID: 34926242 Free PMC article. Review.
-
Current Status: Site-Specific Antibody Drug Conjugates.J Clin Immunol. 2016 May;36 Suppl 1:100-7. doi: 10.1007/s10875-016-0265-6. Epub 2016 Mar 22. J Clin Immunol. 2016. PMID: 27003914 Free PMC article. Review.
-
The Potential of Topoisomerase Inhibitor-Based Antibody-Drug Conjugates.Pharmaceutics. 2022 Aug 16;14(8):1707. doi: 10.3390/pharmaceutics14081707. Pharmaceutics. 2022. PMID: 36015333 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources